Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Home-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary Outcomes.

Coultas DB, Jackson BE, Russo R, Peoples J, Singh KP, Sloan J, Uhm M, Ashmore JA, Blair SN, Bae S.

Ann Am Thorac Soc. 2018 Apr;15(4):470-478. doi: 10.1513/AnnalsATS.201704-308OC.

PMID:
29283670
2.

Can Commercially Available Pedometers Be Used For Physical Activity Monitoring In Patients With COPD Following Exacerbations?

Prieto-Centurion V, Bracken N, Norwick L, Zaidi F, Mutso AA, Morken V, Coultas DB, Rand CS, Marquez DX, Krishnan JA.

Chronic Obstr Pulm Dis. 2016;3(3):636-642.

3.

Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.

Yu YF, Wu N, Chuang CC, Wang R, Pan X, Benjamin NN, Devercelli G, Coultas DB.

J Manag Care Spec Pharm. 2016 Apr;22(4):414-23. doi: 10.18553/jmcp.2016.22.4.414.

4.

A Lifestyle Physical Activity Intervention for Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

Coultas DB, Jackson BE, Russo R, Peoples J, Sloan J, Singh KP, Ashmore J, Blair SN, Uhm M, Bae S.

Ann Am Thorac Soc. 2016 May;13(5):617-26. doi: 10.1513/AnnalsATS.201508-508OC.

5.

Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States.

Wu N, Yu YF, Chuang CC, Wang R, Benjamin NN, Coultas DB.

J Med Econ. 2015 Apr;18(4):249-57. doi: 10.3111/13696998.2014.991789. Epub 2015 Feb 2.

PMID:
25428658
6.

Domain-specific self-efficacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease.

Jackson BE, Coultas DB, Ashmore J, Russo R, Peoples J, Uhm M, Singh KP, Bae S.

Ann Am Thorac Soc. 2014 Mar;11(3):310-5. doi: 10.1513/AnnalsATS.201308-273BC.

7.

Coagulation disorders and the IPF puzzle.

Coultas DB.

Thorax. 2014 Mar;69(3):203-4. doi: 10.1136/thoraxjnl-2013-204245. Epub 2013 Sep 16. No abstract available.

PMID:
24043637
8.

Rural-urban disparities in quality of life among patients with COPD.

Jackson BE, Coultas DB, Suzuki S, Singh KP, Bae S.

J Rural Health. 2013 Aug;29 Suppl 1:s62-9. doi: 10.1111/jrh.12005. Epub 2013 Feb 22.

9.

Predictors of depressive symptoms in patients with COPD and health impact.

Coultas DB, Edwards DW, Barnett B, Wludyka P.

COPD. 2007 Mar;4(1):23-8.

PMID:
17364674
10.

Is idiopathic pulmonary fibrosis an environmental disease?

Taskar VS, Coultas DB.

Proc Am Thorac Soc. 2006 Jun;3(4):293-8. Review.

PMID:
16738192
11.

Undiagnosed airflow obstruction: prevalence and implications.

Coultas DB, Mapel DW.

Curr Opin Pulm Med. 2003 Mar;9(2):96-103. Review.

PMID:
12574688
12.

The health impact of undiagnosed airflow obstruction in a national sample of United States adults.

Coultas DB, Mapel D, Gagnon R, Lydick E.

Am J Respir Crit Care Med. 2001 Aug 1;164(3):372-7.

PMID:
11500335
13.
14.

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB.

Arch Intern Med. 2000 Sep 25;160(17):2653-8.

PMID:
10999980
15.

Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers.

Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA.

Am J Epidemiol. 2000 Aug 15;152(4):307-15.

PMID:
10968375
16.

Utilization in COPD: patient characteristics and diagnostic evaluation.

Mapel DW, Picchi MA, Hurley JS, Frost FJ, Petersen HV, Mapel VM, Coultas DB.

Chest. 2000 May;117(5 Suppl 2):346S-53S.

PMID:
10843975
17.

Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.

Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB.

Thorax. 1998 Jun;53(6):469-76.

18.
19.

Ethnic differences in the prevalence of nonmalignant respiratory disease among uranium miners.

Mapel DW, Coultas DB, James DS, Hunt WC, Stidley CA, Gilliland FD.

Am J Public Health. 1997 May;87(5):833-8.

20.

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future.

Mapel DW, Samet JM, Coultas DB.

Chest. 1996 Oct;110(4):1058-67. Review. No abstract available.

PMID:
8874268

Supplemental Content

Loading ...
Support Center